Abstract:
Iron-regulated surface determinant proteins IsdA, IsdB and IsdC from Staphylococcus aureus, as well as antibodies, antisense nucleic acids and siRNA specific to IsdA, IsdB or IsdC are used as vaccines and in method for treating or preventing a disease or condition associated with S. aureus infections Screening assays for identifying agents that inhibit or interfere with the expression level and/or function of IsdA, IsdB or IsdC are also described.
Abstract:
Vaccines comprising the NEAT domain of iron-regulated surface determinant (Isd) proteins IsdA, IsdB, IsdC, and IsdH (HarA) from Staphylococcus aureus, as well as antibodies, antisense nucleic acids and siRNA specific to the NEAT domains of IsdA, IsdB. IsdC or IsdH (HarA) are described Screening assays for identifying agents that inhibit or interfere with the expression level and/or function of IsdA, IsdB, IsdC or IsdH (HarA) NEAT domain arc also described.
Abstract:
Iron-regulated surface determinant proteins IsdA, IsdB and IsdC from Staphylococcus aureus, as well as antibodies, antisense nucleic acids and siRNA specific to IsdA, IsdB or IsdC are used as vaccines and in method for treating or preventing a disease or condition associated with S. aureus infections Screening assays for identifying agents that inhibit or interfere with the expression level and/or function of IsdA, IsdB or IsdC are also described.
Abstract:
The present invention provides novel anti-infectives that act on Staphylococcus aureus (S. aureus) iron-regulated surface determinants, IsdA, IsdB, and IsdC.